Christiane Hamacher takes up appointment as Head of Asia-Pacific, Roche Pharmaceuticals Christiane Hamacher takes up appointment as Head of Asia-Pacific, Roche Pharmaceuticals Christiane succeeds Alexander Hardy who was appointed Head of Global Product Strategy based in Switzerland 2016-2017 DCAT officers announced 2016-2017 DCAT officers announced The Drug, Chemical & Associated Technologies Association (DCAT) powers relationships and industry knowledge for companies engaged in the business of pharmaceutical development... Elligo Health Research names Dawn East as Vice President of Oncology Operations Elligo Health Research names Dawn East as Vice President of Oncology Operations Elligo helps speed therapies to market by identifying qualified patients and their clinicians and providing the infrastructure that makes it possible for them to participate in... Almac Group appoints Dr Victor Diaz Perez as Head of Physical Sciences Almac Group appoints Dr Victor Diaz Perez as Head of Physical Sciences Dr Diaz will further complement the existing physical sciences team, bringing considerable experience in research and development within solid state chemistry The RSA Group appoints Natalie Walter as new NED to its board The RSA Group appoints Natalie Walter as new NED to its board RSA advises on the selection, assessment and on-boarding of board and senior executive talent BioPharmaSpec appoints two senior technical staff from the CRO and biosimilar fields BioPharmaSpec appoints two senior technical staff from the CRO and biosimilar fields The technical directors will support BioPharmaSpec’s growing structural and physicochemical characterisation business Change in the executive management team of Gerhard Schubert GmbH Change in the executive management team of Gerhard Schubert GmbH Gerald Schubert hands over responsibility to Marcel Kiessling Abzena makes two senior executive appointments to drive growth of international business Abzena makes two senior executive appointments to drive growth of international business Abzena provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products Industry expert Kunal Jaiswal to head strategic development for Catalent’s clinical supply services business Industry expert Kunal Jaiswal to head strategic development for Catalent’s clinical supply services business Mr Jaiswal brings more than 10 years of clinical supply chain operations experience TxCell appoints Dr Li Zhou as VP Cell Engineering to lead its CAR-Treg programmes TxCell appoints Dr Li Zhou as VP Cell Engineering to lead its CAR-Treg programmes CAR-T expert to accelerate R&D efforts and expand the potential of TxCell’s CAR-Treg platform Dr Torsten Mummenbrauer appointed SVP Business Development & Licensing of Hookipa Biotech Dr Torsten Mummenbrauer appointed SVP Business Development & Licensing of Hookipa Biotech Dr Mummenbrauer brings almost 20 years of business development experience in the life science industry, including more than 10 years in vaccines OBN appoints three new directors OBN appoints three new directors New members add considerable sector experience to the board, bringing legal, investment, commercial and general management expertise Immunocore appoints Paul Fry as Chief Financial Officer Immunocore appoints Paul Fry as Chief Financial Officer Paul joins Immunocore with over 20 years' experience in senior positions in the life sciences and telecommunications sectors Kunwar B. Kishore Arora joins APCER Life Sciences as first Global Chief Operating Officer Kunwar B. Kishore Arora joins APCER Life Sciences as first Global Chief Operating Officer Pharmaceutical services firm structures executive team for next growth phase Datwyler Sealing Solutions Division has a new CEO Datwyler Sealing Solutions Division has a new CEO The board of directors of Datwyler Holding has appointed Torsten Maschke to the new CEO of the Sealing Solutions division and made him a member of the executive management team ReViral announces appointment of new Chief Executive Officer ReViral announces appointment of new Chief Executive Officer ReViral is an antiviral drug discovery and development company focused on novel antiviral treatments for diseases caused by the respiratory syncytial virus (RSV)